STAT3 activation in microglia increases pericyte apoptosis in diabetic retinas through TNF-ɑ/AKT/p70S6 kinase

Jang-Hyuk Yun1, Da-Hye Lee2, Han-Seok Jeong2

  • 1Department of Veterinary Pharmacology, College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Gangwondo, Republic of Korea.

Insights

STAT3 activation in microglia drives pericyte apoptosis in diabetic retinopathy (DR) by increasing TNF-α. Targeting this pathway may prevent vision loss in DR patients.

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Diabetic retinopathy (DR) involves pericyte loss, a key early event.
  • The precise mechanisms driving pericyte apoptosis in DR remain unclear.
  • STAT3 activation is linked to inflammation, a factor in retinal damage.

Purpose of the Study:

  • To investigate the role of STAT3 activation in microglia in diabetic retinopathy.
  • To identify the molecular mechanisms linking STAT3 to pericyte apoptosis.
  • To explore STAT3 as a potential therapeutic target for DR.

Main Methods:

  • Analyzed STAT3 activation in diabetic retinas.
  • Examined the role of IFN-γ and IL-6 in STAT3 activation.
  • Utilized gene expression analysis to identify TNF-α as a key mediator.
  • Investigated the effect of microglial STAT3 on pericyte apoptosis using knockout mice.

Main Results:

  • STAT3 activation in diabetic retinas was induced by IFN-γ and IL-6.
  • STAT3 activation in microglia increased TNF-α expression.
  • Microglial TNF-α induced pericyte apoptosis via AKT/p70S6K signaling.
  • Ablation of STAT3 in microglia reduced pericyte apoptosis and TNF-α levels.

Conclusions:

  • STAT3 activation in microglia contributes to pericyte apoptosis in DR.
  • This process involves increased TNF-α expression and subsequent signaling pathway modulation.
  • Targeting microglial STAT3 activation presents a potential therapeutic strategy for DR.